Welcome to the January edition of the Baker McKenzie Ukraine Healthcare Industry Group Newsletter. This is your regular digest of legal developments affecting the life science and healthcare industries in Ukraine.
This edition covers the main developments for the period of December 2016 to January 2017, when a number of new pricing and reimbursement implementing regulations were introduced. In addition, the procedure for reviewing registration materials for pharmaceuticals registered by strict regulatory authorities was approved. More details on these and other important developments in the Ukrainian life science and healthcare industries are described below.
In this issue:
- Reference pricing and reimbursement
- Licensing of pharmaceutical activities
- State registration of pharmaceuticals
- State control over business activities
- Public procurement